Clinical trials
Hyperpigmentation trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
102 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2013 | 5 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 7 |
| 2022 | 12 |
| 2023 | 12 |
| 2024 | 17 |
| 2025 | 12 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 64 |
| Unknown status | 17 |
| Recruiting | 9 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cosmetique Active International | 11 |
| Cryonove Pharma | 9 |
| Revision Skincare | 4 |
| Henry Ford Health System | 3 |
| Alma Lasers Inc. | 2 |
| Cairo University | 2 |
| Derm Research, PLLC | 2 |
| Integrative Skin Science and Research | 2 |
| King Edward Medical University | 2 |
| Mahidol University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperpigmentation | 102 |
| Melanosis | 23 |
| Acne Vulgaris | 11 |
| Skin Diseases | 7 |
| Lentigo | 6 |
| Telangiectasis | 6 |
| Pigmentation Disorders | 5 |
| Vitiligo | 5 |
| Cicatrix | 4 |
| Erythema | 3 |
Trials
Showing 76 to 100 of 102. Each trial links to its page on Pharma Observatory.
2 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.